SCHEMBL31043751

SCHEMBL31043751

COc1ccc(COC(=O)Nc2ccc(NS(=O)(=O)Cc3ccccc3)cc2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 2/20 0.60
TP53 P04637 2/20 0.56
MAPT P10636 2/20 0.56
SMN1; SMN2 Q16637 3/20 0.55
RAB9A P51151 2/20 0.55
NPC1 O15118 1/20 0.55
PGR P06401 1/20 0.54
HDAC8 Q9BY41 2/20 0.54
LMNA P02545 1/20 0.53
HPGD P15428 1/20 0.52
ALDH1A1 P00352 3/20 0.50
NAMPT P43490 1/20 0.50
POLB P06746 1/20 0.50
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
ACHE P22303 1/20 0.50
ATM Q13315 1/20 0.49
ADRB2 P07550 1/20 0.49
ADRB1 P08588 1/20 0.49
ADRB3 P13945 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1223807 0.87 RAB9A (0.67) TP53MAPTSMN1; SMN2RAB9ANPC1
SCHEMBL31043761 0.86 AR (0.55) ARTP53MAPTSMN1; SMN2RAB9A
SCHEMBL11813314 0.84 TP53 (0.68) TP53MAPTSMN1; SMN2RAB9ANPC1
SCHEMBL6743384 0.83 MAPT (0.62) TP53MAPTSMN1; SMN2RAB9ANPC1
SCHEMBL23747417 0.82 NPC1 (0.71) SMN1; SMN2RAB9ANPC1NAMPTCA2
SCHEMBL6401410 0.81 CA1 (0.54) ARMAPTSMN1; SMN2RAB9ANPC1
SCHEMBL3034797 0.79 MIF (0.60) TP53MAPTSMN1; SMN2RAB9ANPC1
SCHEMBL28221690 0.78 HDAC8 (0.62) ARTP53MAPTSMN1; SMN2RAB9A
SCHEMBL6466509 0.77 MET (0.61) MAPTSMN1; SMN2RAB9ANPC1ALDH1A1
SCHEMBL29031236 0.77 PGR (0.68) ARMAPTSMN1; SMN2PGRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240279215-A1 NAMPT MODULATORS CYTOKINETICS, INCORPORATED 2024-08-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240279215-A1 NAMPT MODULATORS NAMPT, SIRT1, NNT AR 924/4885TP53 4825/4885MAPT 766/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.